CL-ACP: a parallel combination of CNN and LSTM anticancer peptide recognition model
Background: Anticancer peptides are defence substances with innate immune functions that can selectively act on cancer cells without harming normal cells and many studies have been conducted to identify anticancer peptides. In this paper, we introduce the anticancer peptide secondary structures as a...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |